Lash et al.
1
(2H, s), 8.96 (2H, s), 9.29 (2H, d, J ) 10 Hz); H NMR (TFA-
vis (1% Et3N-CHCl3) λmax (log ꢀ) 373 (4.85), 405 (4.79), 451
(4.82), 479 (4.93), 646 nm (4.37); UV-vis (1% TFA-CHCl3) λmax
(log ꢀ) 387 (4.85), 471 (5.09), 650 nm (4.56); 1H NMR (CDCl3) δ
1.47 (6H, t, J ) 7.8 Hz), 3.03 (6H, br s), 3.17-3.28 (4H, br q),
7.50-7.63 (9H, m), 7.73 (4H, d, J ) 7 Hz), 7.78 (2H, d, J ) 7
CDCl3) δ -2.91 (1H, s), -1.79 (1H, v br), -0.11 (2H, br s), 1.66
(6H, t, J ) 7.8 Hz), 1.75 (6H, t, J ) 7.6 Hz), 3.47 (6H, s), 3.81-
3.90 (8H, 2 overlapping quartets), 7.69-7.75 (3H, m), 7.89-7.92
(2H, m), 8.77 (2H, d, J ) 10.4 Hz), 9.50 (2H, s), 9.97 (2H, d, J )
11.2 Hz), 10.39 (2H, s); 1H NMR (pyridine-d5) δ 1.56-1.62 (12H,
2 overlapping triplets), 3.02 (6H, s), 3.38-3.46 (8H, 2 overlapping
quartets), 3.7 (1H, v br), 3.78 (1H, s), 7.5-7.6 (3H, m, obscured
by solvent), 7.85-7.87 (2H, m), 7.95 (2H, d, J ) 10.4 Hz), 8.47
(2H, s), 9.52 (2H, s), 9.70 (2H, d, J ) 10.8 Hz); 1H NMR (acetone-
d6) δ 1.56 (6H, t, J ) 7.6 Hz), 1.66 (6H, t, J ) 7.4 Hz), 3.03 (6H,
s), 3.39 (4H, q, J ) 7.6 Hz), 3.56 (4H, q, J ) 7.4 Hz), 7.59-7.63
(1H, m), 7.68 (2H, t, J ) 7.4 Hz), 7.96 (2H, d, J ) 7.2 Hz), 8.12
(2H, d, J ) 10.4 Hz), 8.24 (2H, br s), 9.26 (2H, s), 9.74 (2H, d, J
1
Hz), 7.89 (2H, br), 8.24 (2H, br), 9.08 (2H, br), 9.35 (2H, br); H
NMR (TFA-CDCl3) δ -2.69 (1H, s), 0.7 (2H, v br), 1.57 (6H, t,
J ) 7.6 Hz), 3.44 (6H, s), 3.67 (4H, q, J ) 7.6 Hz), 7.65-7.71
(9H, m), 7.80-7.83 (4H, m), 7.86-7.90 (2H, m), 8.69 (2H, d, J )
10.4 Hz), 9.47 (2H, s), 9.93 (2H, d, J ) 10.8 Hz), 10.36 (2H, s);
1H NMR (pyridine-d5) δ 1.50 (6H, t, J ) 7.6 Hz), 3.05 (6H, s),
3.25 (4H, q, J ) 7.6 Hz), 3.35 (1H, br s), 3.5 (1H, v br), 7.47-
7.61 (9H, m), 7.87-7.93 (6H, m), 8.02 (2H, d, J ) 10.8 Hz), 8.68
(2H, s), 9.68 (2H, s), 9.79 (2H, d, J ) 10.4 Hz); 13C NMR (TFA-
CDCl3) δ 11.5, 15.9, 19.6, 98.6, 109.5, 123.7, 128.7, 128.9, 129.2,
129.3, 130.0, 131.1, 132.0, 132.6,139.1, 141.0, 141.4, 141.9, 142.1,
142.5, 145.1, 146.8, 152.2, 160.3; HRMS (EI) calcd for C50H41N3
+ 2H m/z 685.3457, found 685.3457. Anal. Calcd for C50H41N3‚
1/8CHCl3: C, 86.15; H, 5.93; N, 6.01. Found: C, 85.87; H, 5.81;
N, 6.23.
1
) 10.8 Hz); H NMR (DMF-d7) δ 1.57 (6H, t, J ) 7.4 Hz), 1.66
(6H, t, J ) 7.6 Hz), 2.80 (1H, s), 3.08 (6H, s), 3.42 (4H, q, obscured
by water peak), 3.60 (4H, q, J ) 7.6 Hz), 7.61-7.65 (1H, m), 7.67-
7.72 (2H, m), 8.02-8.05 (2H, m), 8.20 (2H, d, J ) 10.8 Hz), 8.34
(2H, s), 9.45 (2H, s), 9.96 (2H, d, J ) 10.4 Hz); 1H NMR (DMSO-
d6) δ 1.52 (6H, t, J ) 7.6 Hz), 1.60 (6H, t, J ) 7.6 Hz), 3.04 (6H,
s), 3.37 (4H, q, J ) 7.6 Hz), 3.54 (4H, q, J ) 7.5 Hz), 7.59-7.63
(1H, m), 7.66-7.70 (2H, m), 7.97 (2H, d, J ) 7.2 Hz), 8.17 (2H,
d, J ) 10.8 Hz), 8.25 (2H, s), 9.36 (2H, s), 9.87 (2H, d, J ) 11.2
Hz); 13C NMR (CDCl3) δ 11.1, 16.6, 17.1, 19.1, 19.3, 93.4, 108.1,
126.9, 128.3, 129.0, 129.3, 131.9, 134.2, 136.9, 139.6, 139.9, 142.0,
143.1, 144.0, 147.4, 153.7, 155.5, 162.1; 13C NMR (TFA-CDCl3)
δ 11.6, 16.0, 16.9, 19.7, 19.8, 95.1, 110.1, 123.6, 128.7, 129.0,
130.2, 131.4, 139.4, 141.4, 141.9, 142.1, 142.3, 144.1, 144.9, 147.1,
152.4; HRMS (EI) calcd for C42H41N3 + 2H m/z 589.3457, found
589.3454. Anal. Calcd for C40H45N3‚1/4CHCl3: C, 82.16; H, 6.73;
N, 6.80. Found: C, 82.05; H, 6.70; N, 6.85.
23-tert-Butyl-7,12,13,18-tetraethyl-8,17-dimethylazuliporphy-
rin (19a). Azulitripyrrane analogue 18a (220 mg; 0.35 mmol) was
stirred in TFA (6 mL) under nitrogen for 10 min. The reaction
mixture was diluted with dichloromethane (200 mL), 3,4-dieth-
ylpyrrole-2,5-dicarbaldehyde32,33 (63 mg; 0.35 mmol) was added,
and the reaction mixture was stirred overnight in the dark. The
solution was shaken vigorously in a separatory funnel with 0.1%
aqueous ferric chloride solution (300 mL) for 5 min. The organic
layer was separated and the aqueous solution back-extracted with
chloroform. The combined organic solutions were washed with
water and then with 5% aqueous sodium bicarbonate, and the
organic phase was dried over sodium sulfate and evaporated under
reduced pressure. The residue was purified on a grade 3 basic
alumina column, eluting with chloroform, and the product was
collected as a deep green fraction that followed a brown prefraction.
The solvent was removed on a rotary evaporator and the residue
recrystallized from chloroform-hexanes to give the tert-butylazu-
liporphyrin (102.3 mg; 0.18 mmol; 51%) as dark purple crystals:
mp >300 °C; UV-vis (1% Et3N-CHCl3) λmax (log ꢀ) 357 (4.78),
400 (sh), 446 (4.64), 474 (4.75), 663 nm (4.15); UV-vis (1%
TFA-CHCl3) λmax (log ꢀ) 365 (4.81), 460 (5.00), 634 (4.41), 728
nm (3.83); UV-vis (1% pyrrolidine-CHCl3) λmax (log ꢀ) 368
(4.65), 402 (4.68), 445 (4.57), 473 (4.59), 619 nm (4.01); UV-vis
(5% pyrrolidine-CHCl3) λmax (log ꢀ) 368 (4.62), 402 (4.62), 449
(4.59), 581 nm (4.11); UV-vis (10% pyrrolidine-CHCl3) λmax (log
ꢀ) 397 (4.58), 451 (4.60), 586 nm (4.11); 1H NMR (CDCl3) δ 1.61
(9H, s), 1.58-1.65 (12H, 2 overlapping triplets), 2.8 (1H, v br),
2.86 (1H, br), 2.92 (6H, s), 3.43-3.52 (2 overlapping quartets),
7.92 (2H, d, J ) 10.8 Hz), 8.16 (2H, s), 9.04 (2H, s), 9.35 (2H, d,
23-tert-Butyl-8,17-diethyl-7,18-dimethyl-12,13-diphenylazuli-
porphyrin (16b). Tripyrrane 6b4b (100 mg; 0.182 mmol) was
reacted with 6-tert-butyl-1,3-azulenedicarbaldehyde (44 mg; 0.183
mmol) under the foregoing conditions. The crude product was
chromatographed on grade 3 basic alumina, eluting with chloroform,
and recrystallized from chloroform-hexanes to afford the porphyrin
analogue (66 mg; 0.10 mmol; 55%) as purple crystals: mp
>300 °C; UV-vis (1% Et3N-CHCl3) λmax (log ꢀ) 371 (4.79), 405
(4.74), 433 (4.77), 477 (4.79), 557 (4.06), 677 nm (4.24); UV-vis
(1% TFA-CHCl3) λmax (log ꢀ) 374 (4.81), 466 (4.97), 644 nm
(4.42); 1H NMR (CDCl3) δ 1.50 (6H, t, J ) 7.6 Hz), 1.62 (9H, s),
2.49 (1H, br s), 2.8 (1H, v br), 3.04 (6H, s), 3.25 (4H, q, J ) 7.6
Hz), 7.49-7.59 (6H, m), 7.77 (4H, d, J ) 8 Hz), 7.95 (2H, d, J )
10.4 Hz), 8.33 (2H, s), 9.17 (2H, s), 9.39 (2H, d, J ) 10.4 Hz); 1H
NMR (TFA-CDCl3) δ -3.43 (1H, s), -1.8 (1H, v br), -0.53 (2H,
br s), 1.58 (6H, t, J ) 7.8 Hz), 1.73 (9H, s), 3.49 (6H, s), 3.74
(4H, q, J ) 7.6 Hz), 7.68-7.74 (6H, m), 7.82-7.85 (4H, m), 8.85
(2H, d, J ) 10.8 Hz), 9.66 (2H, s), 9.98 (2H, d, J ) 10.4 Hz), 10.5
1
J ) 10.8 Hz); H NMR (TFA-CDCl3) δ -3.33 (1H, s), -2.30
1
(2H, s, obscured by TFA); H NMR (pyridine-d5) δ 1.50 (9H, s),
(1H, br), -0.60 (2H, s), 1.65 (9H, s), 1.61-1.70 (12H, 2
overlapping triplets), 3.31 (6H, s), 3.81 (4H, q, J ) 7.8 Hz), 3.87
(4H, q, J ) 7.8 Hz), 8.75 (2H, d, J ) 10.4 Hz), 9.51 (2H, s), 9.88
(2H, d, J ) 10.4 Hz), 10.32 (2H, s); 1H NMR (pyridine-d5) δ 1.49
(9H, s), 1.61 (6H, t, J ) 7.6 Hz), 1.67 (6H, t, J ) 7.6 Hz), 2.98
(6H, s), 3.27 (1H, v br), 3.35 (1H, s), 3.49 (4H, q, J ) 7.6 Hz),
3.59 (4H, q, J ) 7.5 Hz), 7.87 (2H, d, J ) 10.4 Hz), 8.58 (2H, s),
1.52 (6H, t, J ) 7.2 Hz), 2.90 (1H, br s), 3.14 (6H, s), 3.30 (4H,
q, J ) 7.6 Hz), 7.50 (2H, t, J ) 7.4 Hz), 7.60 (4H, t, J ) 7.4 Hz),
7.92-7.98 (6H, m), 8.79 (2H, s), 9.63 (2H, d, J ) 10.8 Hz), 9.72
(2H, s); 13C NMR (CDCl3) δ 11.2, 16.5, 19.3, 31.9, 39.1, 96.5,
108.1, 126.8, 127.8, 128.5, 130.9, 132,1, 134.5, 134.9, 135.8, 139.3,
139.5, 141.9, 142.4, 148.8, 155.4, 161.5, 164.7; 13C NMR (TFA-
CDCl3) δ 11.5, 15.8, 19.6, 31.6, 40.6, 98.4, 109.6, 123.7, 129.0,
129.4, 129.6, 132.0,139.4, 141.4, 142.2, 142.4, 142.7, 146.3, 153.4,
173.6; HRMS (EI) calcd for C48H45N3 + 2H m/z 655.3770; found:
655.3771. Anal. Calcd for C48H45N3‚0.3CHCl3: C, 82.91; H, 6.52;
N, 6.01. Found: C, 82.88; H, 6.46; N, 6.25.
1
9.57 (2H, d, J ) 10 Hz), 9.58 (2H, s); H NMR (10 drops of
pyrrolidine-d8-CDCl3; peaks for 22-pyrrolidine adduct 25a only)
δ -7.06 (1H, s), -4.5 (2H, v br), 1.13 (9H, s,), 2.18-2.23 (12H,
2 overlapping triplets), 3.35 (6H, obscured by solvent impurities),
3.68 (4H, q, J ) 7.6 Hz), 3.82 (4H, q, J ) 7.6 Hz), 5.03 (1H, d,
J ) 7.6 Hz), 6.07 (1H, d, J ) 8 Hz), 6.98 (1H, d, J ) 12 Hz), 8.15
(1H, d, J ) 12 Hz), 9.46 (1H, s), 9.47 (1H, s), 9.73 (1H, s), 9.91
(1H, s); 13C NMR (CDCl3) δ 11.0, 17.1, 17.3, 19.1, 19.5, 31.9,
39.0, 93.2, 107.9, 126.6, 130.2, 134.2, 134.8, 136.2, 139.9, 142.8,
8,17-Diethyl-7,18-dimethyl-23,12,13-triphenylazuliporphy-
rin (17b). Tripyrrane 6b4b (100 mg; 0.182 mmol) was reacted with
6-phenyl-1,3-azulenedicarbaldehyde (47 mg; 0.181 mmol) under
the foregoing conditions. The crude product was chromatographed
on grade 3 basic alumina, eluting with chloroform, and recrystallized
from chloroform-hexanes to afford the porphyrin analogue (83
mg; 0.12 mmol; 67%) as a dark green powder: mp >300 °C; UV-
(33) Tardieux, C.; Bolze, F.; Gros, C. P.; Guilard, R. Synthesis 1998,
267-268.
8412 J. Org. Chem., Vol. 72, No. 22, 2007